NCT00350870View on ClinicalTrials.gov

CBT With Disulfiram and Contingency Management

PHASE1CompletedINTERVENTIONAL
Enrollment

181

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Cocaine Abuse
Interventions
DRUG

disulfiram

250mg per day of Disulfiram plus CBT

DRUG

Placebo

Placebo plus CBT

BEHAVIORAL

Placebo plus Contingency Management

Placebo plus Contingency Management for cocaine abstinence and medication compliance in addition to CBT

DRUG

Disulfiram plus Contingency Management

250mg of Disulfiram plus Contingency Management for cocaine abstinence and medication compliance plus CBT.

Trial Locations (1)

06510

APT Foundation, New Haven

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00350870 - CBT With Disulfiram and Contingency Management | Biotech Hunter | Biotech Hunter